Has Pranitha Prodduturvar, MD received payments from drug or device companies?

Yes. Drug and device makers reported $909,837 in general payments to Pranitha Prodduturvar, MD across 569 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Pranitha Prodduturvar, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Pranitha Prodduturvar, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Pranitha Prodduturvar, MD

Medical Oncology · Mobile, ALNPI 1114183902

Payments from drug & device makers

$909,837in general payments, 2019–2025

Across 569 payments — averaging $1599.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Seagen Inc.$295K
E.r. Squibb & Sons, L.L.C.$212K
Merck$196K
AstraZeneca$125K
Genentech, Inc.$44K
Amgen$27K
plus $11K from 50 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Seagen Inc.	64	$295,101
E.r. Squibb & Sons, L.L.C.	48	$211,939
Merck	27	$195,767
AstraZeneca(2 entities)	37	$125,057
Genentech, Inc.	4	$44,300
Amgen	27	$26,854
Pfizer	19	$3,346
Sanofi	10	$1,472
Johnson & Johnson	32	$613
Novartis	34	$608
Regeneron Healthcare Solutions, Inc.	28	$607
Eisai Inc.	35	$565
Incyte Corporation	30	$502
Bristol Myers Squibb	22	$421
Daiichi Sankyo Inc.	19	$388
Takeda Pharmaceuticals U.S.A., Inc.	12	$306
Genentech USA, Inc.	14	$226
Array Biopharma Inc	17	$165
Dendreon Pharmaceuticals LLC	4	$105
AbbVie	4	$104
Pharmaessentia USA Corporation	5	$93
Lilly USA, LLC	5	$82
Beigene USA, Inc.	5	$81
Gilead	4	$75
Stemline Therapeutics Inc.	4	$74
Sobi, Inc	3	$55
EMD Serono, Inc.	2	$53
Exelixis Inc.	3	$53
Blueprint Medicines Corporation	3	$51
ADC Therapeutics America, Inc.	3	$50
Astellas Pharma US Inc	3	$46
Karyopharm Therapeutics Inc.	3	$45
Syndax Pharmaceuticals, Inc.	2	$45
Puma Biotechnology, Inc.	3	$45
GSK	3	$45
Pharmacosmos Therapeutics Inc.	3	$44
Tersera Therapeutics LLC	2	$38
Rigel Pharmaceuticals, Inc.	2	$33
Bayer	2	$32
Mirati Therapeutics, Inc.	2	$31
Azurity Pharmaceuticals, Inc.	1	$31
Taiho Oncology, Inc.	2	$30
Springworks Therapeutics, Inc.	2	$30
Genmab U.S., Inc.	2	$29
Morphosys, US Inc.	2	$28
Agios Pharmaceuticals, Inc.	1	$21
Beone Medicines USA, Inc.	1	$19
Geron Corporation	1	$17
Deciphera Pharmaceuticals Inc.	1	$16
Immunogen, Inc.	1	$16
AVEO Pharmaceuticals, Inc.	1	$16
Apellis Pharmaceuticals, Inc.	1	$15
Servier Pharmaceuticals LLC	1	$14
Myovant Sciences Inc.	1	$13
Veracyte, Inc.	1	$12
Clovis Oncology, Inc.	1	$12

How this compares

$909,837 in reported general payments places this provider in the 85th percentile of 30 medical oncology providers in Alabama.

See all medical oncology providers in Alabama →

Medicare billing

Part B allowed, 2024

$30,470

Medicare patients

103

Services billed

303

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other medical oncology in Mobile

Sachin PaiMobile$2.1M
Norma NordenMobile$2K
Syed Abbas AliJasper$3M
Joelle HamiltonHomewood$2.2M
Marshall SchreederHuntsville$1.1M
John DubayTuscaloosa$756K
Sunil RangarajanBirmingham$576K
James DaughertyFlorence$119K
Hemant PatelMuscle Shoals$61K
Johnny NacillaCullman$23K

See the full list for Alabama →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →